Workflow
WBA Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Walgreens Boots Alliance to Sycamore Partners
WBAWalgreens Boots Alliance(WBA) GlobeNewswire News Room·2025-03-07 00:26

Core Viewpoint - The law firm Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Walgreens Boots Alliance, Inc. to Sycamore Partners for 11.45pershareincash,withpotentialadditionalcashfromfuturemonetizationofVillageMDbusinesses[1][3].Group1:SalePriceConcerns−Thesalepriceof11.45 per share in cash, with potential additional cash from future monetization of VillageMD businesses [1][3]. Group 1: Sale Price Concerns - The sale price of 11.45 per share is below the price targets set by at least two Wall Street analysts, even when considering the potential additional 3.00pershare[2][4].−AnalystsLisaGillofJ.P.MorganandCharlesRhyeeofTDCowenhavesetpricetargetsof3.00 per share [2][4]. - Analysts Lisa Gill of J.P. Morgan and Charles Rhyee of TD Cowen have set price targets of 15.00 per share, while three other analysts have targets of 12.00pershare[4].−Severalshareholdershaveexpresseddisappointmentregardingthesaleprice,withcommentsindicatingfeelingsofbeing"robbed"andthatitisa"terribledealforshareholders"[5].Group2:InvestigationRationale−TheinvestigationaimstodetermineiftheWalgreensBoardofDirectorsactedinthebestinterestsofshareholderswhenapprovingthesaleandwhethertheagreedpriceisfair[6].−Theinvestigationwillalsoassessifallmaterialinformationregardingthetransactionhasbeenfullydisclosedtoshareholders[6].Group3:MarketContext−ThesalepriceissignificantlylowerthanWalgreens′52−weekhighof12.00 per share [4]. - Several shareholders have expressed disappointment regarding the sale price, with comments indicating feelings of being "robbed" and that it is a "terrible deal for shareholders" [5]. Group 2: Investigation Rationale - The investigation aims to determine if the Walgreens Board of Directors acted in the best interests of shareholders when approving the sale and whether the agreed price is fair [6]. - The investigation will also assess if all material information regarding the transaction has been fully disclosed to shareholders [6]. Group 3: Market Context - The sale price is significantly lower than Walgreens' 52-week high of 22.05, suggesting that the deal may be opportunistic [5].